Clinical trials recruiting in Arkhangelsk, Russia
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 1Phase 3 3Not applicable 3
Conditions recruiting in Arkhangelsk, Russia
Recruiting trials in Arkhangelsk, Russia
- A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI
- A Long-term Extension Study of PCI-32765 (Ibrutinib)
- A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
- Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
- BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
- Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
- The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
Common questions
How many clinical trials are recruiting in Arkhangelsk, Russia?
8 recruiting trials have at least one study site in Arkhangelsk, Russia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.